Antimicrobial therapy in dermatology;Antimikrobielle therapie in der dermatologie

JDDG - Journal of the German Society of Dermatology

Volumn 4, Issue 1, 2006, Pages 10-27

  Sunderkötter, Cord ^a,b   Herrmann, Mathias ^c   Jappe, Uta ^d  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

lactam resistance; Antibiotics; Antiseptics; Soft tissue infection

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEFUROXIME; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLAVULANIC ACID; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DICLOXACILLIN; FLUCLOXACILLIN; GLYCOPEPTIDE; LEVOFLOXACIN; LINCOSAMIDE; LINEZOLID; MACROLIDE; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; OXACILLIN; PENICILLIN G; PENICILLIN V; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULBACTAM; SULTAMICILLIN; TEICOPLANIN; TETRACYCLINE; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTERIAL INFECTION; BLOOD CLOTTING DISORDER; CENTRAL NERVOUS SYSTEM DISEASE; CHLAMYDIASIS; CHOLESTATIC HEPATITIS; DERMATOLOGY; DIABETES MELLITUS; DIARRHEA; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; EHRLICHIOSIS; ENDOCARDITIS; EOSINOPHILIA; ERYSIPELAS; FEVER; GASTROINTESTINAL SYMPTOM; GONORRHEA; HEART VENTRICLE ARRHYTHMIA; HEMOLYTIC ANEMIA; HEPATITIS; HERXHEIMER REACTION; HUMAN; HYPERTENSION; HYPOTENSION; IMMEDIATE TYPE HYPERSENSITIVITY; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; LIVER DISEASE; LIVER DYSFUNCTION; LYME DISEASE; MACULOPAPULAR RASH; MALAISE; MEDICAL PRACTICE; MENTAL DISEASE; MYASTHENIA GRAVIS; NAUSEA; NEPHROTOXICITY; NEUROSYPHILIS; NEUTROPENIA; OTOTOXICITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHLEBITIS; PRESCRIPTION; PSEUDOMEMBRANOUS COLITIS; REVIEW; RICKETTSIOSIS; SEIZURE; SEXUALLY TRANSMITTED DISEASE; SKIN INFECTION; SKIN SENSITIZATION; SKIN TEST; SLEEP DISORDER; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STOMACH PARESIS; SYSTEMIC SCLEROSIS; THRUSH; TONIC CLONIC SEIZURE; URETHRITIS; UROGENITAL TRACT INFECTION; VOMITING;

ADMINISTRATION, TOPICAL; ANTI-INFECTIVE AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BACTERIAL INFECTIONS; CEPHALOSPORINS; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; GERMANY; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLINS; PRACTICE GUIDELINES; SKIN DISEASES, INFECTIOUS;

EID: 33645237520     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2006.05901.x     Document Type: Review

References (39)

1. Fung HB, Chang JY, Kuczynski S. A practical guide to the treatment of complicated skin and soft tissue infections. Drugs 2003; 63: 1459-1480.
2. Alanis AJ. Resistance to antibiotics: are we in the post-antibiotic era? Arch Med Res. 2005; 36: 697-705.
3. Ayliffe GA, Green W, Livingston R, Lowbury EJ. Antibiotic-resistant Staphylococcus aureus in dermatology and burn wards. J Clin Pathol 1977; 30: 40-44.
4. Schöfer H, Brockmeyer N, Dissemond J, Effendy I, Esser S, Geiss H, Harder S, Hartmann M, Jappe U, Plettenberg A, Reimann H, Shah P, Tschachler E, Wichelhaus T. Staphylokokken-Infektionen der Haut und Schleimhäute. Leitlinie der Deutschen Dermatologischen Gesellschaft (DDG), Arbeitsgemeinschaft für Dermatologische Infektiologie. JDDG 2005; 3: 726-734.
5. Kühnen E, Fischer R, Hartinger A, Heuck D, Oettinger W, Schmidt E, Schumacher U, Wagner J. Infektionen der Haut- und subkutanen Weichteile. MiQ 6 Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik. Urban und Fischer Verlag München 1999.
6. Doern GV, Jones RN, Pfaller MA, Kugler KC, Beach ML. Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America). Diagn Microbiol Infect Dis 1999; 34: 65-72.
7. Brockmeyer NH. Syphilis. In: Petzoldt D, Gross G. Diagnostik und Therapie sexuell übertragbarer Krankheiten. Leitlinien 2001 der Deutschen STD-Gesellschaft. 1. Auflage Heidelberg, Springer Verlag 2001; 101-111.
8. Gross G. Stellungnahme der DSTDG zur aktuellen Situation der Syphilistherapie in Deutschland. Hautarzt 2003; 54: 1018.
9. Nathwani D, Wood MJ. Penicillins. A current review of their clinical pharmacology and therapeutic use. Drugs 1993; 45: 866-894.
10. Fairley, CK, Boyd I, Purcell P, McNeil J. Flucloxacillin jaundice. Lancet 1992; 339: 679.
11. Mandell GL, Bennett JE, Dolin R (Editors). Principles & Practice of Infectious Diseases Publisher: Churchill Livingstone; 5th edition 2000).
12. Neu, HC. Diagnosis and treatment: drugs five years later. Amoxicillin. Ann Int Med 1979; 90: 356.
13. Renn CN, Straff W, Dorfmüller A, Al-Masoudi T, Merk HF, Sachs B. Amoxicillin-induced exanthema in young adults with infectious mononucleosis: demonstration of drug-specific lymphocyte reactivity. Br J Dermatol 2002; 147: 1166-1170.
14. Tricka J, Schäd SG, Pfeuffer P, Raith P, Bröcker EB, Trautmann A. Penicillintherapie trotz Penicillinallergie? DÄB 2003; 100: 2888-2892.
15. Vega JM, Blanca M, Garcia JJ, Carmona MJ, Miranda A, Perez-Estrada M, Fernandez S, Acebes JM, Terrados S. Immediate allergic reactions to amoxicillin. Allergy 1994; 49: 317-322.
16. Moellering, RC, Jr. Importance of beta-lactamase inhibitors in overcoming bacterial resistance. Infect Dis Clin Pract 1998;4(suppl. 1):S1.
17. Lees L, Milson JA, Knisch AK, Greenhalgh K. Sulbactam plus ampicillin: interim review of efficacy and safety for therapeutic and prophylactic use. Rev Inf Dis 1986; 8 (suppl5): S644-S650.
18. Ball P, Geddes A, Rolinson G. Amoxycillin clavulanate: an assessment after 15 years of clinical application. J Chemother 1997; 9: 167-198.
19. Kelkar PS. Cephalosporin allergy. N Engl J Med 2001; 345: 804-809.
20. Boguniewicz M. Adverse reactions to antibiotics: is the patient really allergic? Drug Saf 1995; 13: 273-280.
21. Romano A, Mayorga C, Torres MJ, et al. Immediate allergic reactions to cephalosporins: cross-reactivity and selective response. J Allergy Clin Immunol 2000; 106: 17-63.
22. Kretschmer L, Zimmermann O, Stein A, Sebastian G; Commission for Quality Assurance of the German Dermatology Society and the Professional Association of Surgical and Oncological Dermatology. [Perioperative antibiotic therapy in dermatology. Guidelines of the Commission for Quality Assurance of the German Dermatology Society and the Professional Association of Surgical and Oncological Dermatology] Hautarzt. 2001; 52: 609-614.
23. Dattwyler RJ, Halperin JJ, Pass H, Luft BJ. Ceftriaxone as effective therapy in refractory Lyme disease. J Infect Dis 1987; 155: 1322-1325.
24. Reinert RR, Franken C, Van Der Linden M, Lutticken R, Cil M, Al-Lahham A. Molecular characterization of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003. Int J Antimicrob Agents 2004; 24: 43-47.
25. Ray WA, Murray KT, Meredith S, Narasimhulu SS, Hall K, Stein CM. Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med 2004; 351: 1089-1096.
26. Stevens DL, Bryant AE, and Hackett SP. Antibiotic effects on bacterial viability, toxin production, and host response. Clin Infect Dis 1995; 30: S154-S157.
27. Schweiger ES, Weinberg JM. Novel antibacterial agents for skin and skin structure infections. J Am Acad Dermatol 2004; 50: 331-340.
28. Pruzanski W, Greenwald RA, Street IP, Laliberte F, Stefanski E, Vadas P. Inhibition of enzymatic activity of phospholipases A2 by minocycline and doxycycline. Biochem Pharmacol 1992; 44: 1165-1170.
29. Iwasaki H, Inoue H, Mitsuke Y, Badran A, Ikegaya S, Ueda T. Doxycycline induces apoptosis by way of caspase-3 activation with inhibition of matrix metalloproteinase in human T-lymphoblastic leukemia CCRF-CEM cells. J Lab Clin Med 2002; 140: 382-386.
30. Sadowski T, Steinmeyer J. Effects of tetracyclines on the production of matrix metalloproteinases and plasminogen activators as well as of their natural inhibitors, tissue inhibitor of metalloproteinases-1 and plasminogen activator inhibitor-1. Inflamm Res 2001; 50: 175-182.
31. Ross JI, Snelling AM, Carnegie E, Coates P, Cunliffe WJ, Bettoli V, Tosti G, Katsambas A, Galvan Perez Del Pulgar JI, Rollman O, Torok L, Eady EA, Cove JH. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003; 148: 467-478.
32. Jappe U, Schnuch A, Uter W. Sensitizing potential of antimicrobials in patients with atopic eczema compared to non-atopic individuals: analysis of multicentre surveillance data, 1995-1999. Br J Dermatol 2003; 149: 87-93.
33. Ozolins M, Eady EA, Avery AJ, Cunliffe WJ, Li Wan Po A, O'Neill C, Simpson NB, Walters CE, Carnegie E, Lewis JB, Dada J, Haynes M, Williams K, Williams HC. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet 2004; 364: 2188-2195.
34. Heise H. Gonorrhoeae. In: Petzoldt D, Gross G. Diagnostik und Therapie sexuell übertragbarer Krankheiten. Leitlinien 2001 der Deutschen STD-Gesellschaft. 1. Auflage Heidelberg, Springer Verlag 2001: 31-38.
35. Jones RN. Ceftibuten: a review of antimicrobial activity, spectrum and other microbiologic features. Pediatr Infect Dis 1995; 14: S77-S83.
36. Paladino JA. Linezolid: an oxazolidinone antimicrobial agent. Am J Health Syst Pharm 2002; 59: 2413-2425.
37. Bressler AM, Zimmer SM, Gilmore JL, Somani J. Peripheral neuropathy associated with prolonged use of line-zolid. Lancet Infect Dis 2004; 4: 528-531.
38. Talan DA, Summanen PH, Finegold SM. Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse. Clin Infect Dis 2000; 31: 464-471.
39. th edition Sanford Guide 2004.